Le doripénème: quelle place pour un nouveau carbapénème? [Doripenem: need for a new carbapenem]

Détails

ID Serval
serval:BIB_BE16AB9FFE43
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Le doripénème: quelle place pour un nouveau carbapénème? [Doripenem: need for a new carbapenem]
Périodique
Medecine et maladies infectieuses
Auteur⸱e⸱s
Guery B.P.
ISSN
1769-6690 (Electronic)
ISSN-L
0399-077X
Statut éditorial
Publié
Date de publication
12/2009
Peer-reviewed
Oui
Volume
39
Numéro
12
Pages
871-876
Langue
français
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
Doripenem is a new member of the carbapenem family. Its spectrum is a little wider than meropenem and it is active on some Pseudomonas aeruginosa strains resistant to other carbapenems and on Burkholderia cepacia. Doripenem was evaluated in nosocomial pneumonia including ventilator-acquired pneumonia, complicated intra-abdominal infection, and complicated urinary tract infection. In nosocomial pneumonia, doripenem showed an interesting activity in P. aeruginosa infected patients. This data, along with the global increase in multiresistance, may be an opportunity to optimize our therapeutic options with a new molecule.
Mots-clé
Animals, Anti-Bacterial Agents/adverse effects, Anti-Bacterial Agents/chemistry, Anti-Bacterial Agents/economics, Anti-Bacterial Agents/pharmacology, Anti-Bacterial Agents/therapeutic use, Bacterial Infections/drug therapy, Burkholderia cepacia/drug effects, Carbapenems/adverse effects, Carbapenems/chemistry, Carbapenems/economics, Carbapenems/pharmacology, Carbapenems/therapeutic use, Clinical Trials as Topic, Cross Infection/drug therapy, Doripenem, Drug Evaluation, Preclinical, Drug Resistance, Multiple, Bacterial, Humans, Nervous System Diseases/chemically induced, Peritonitis/drug therapy, Pneumonia, Bacterial/drug therapy, Pseudomonas aeruginosa/drug effects, Urinary Tract Infections/drug therapy
Pubmed
Web of science
Création de la notice
29/04/2021 9:59
Dernière modification de la notice
17/07/2023 12:42
Données d'usage